medigraphic.com

2011, Number 4

<< Back Next >>

Rev Mex Med Repro 2011; 3.4 (4)

The role of proteomics in defining the human embryonic secretome

Katz JMG, McReynolds S, Gardner DK, Schoolcraft WB

Language: Spanish
References: 45
Page: 150-159
PDF size: 159.47 Kb.


ABSTRACT

Non-invasive gamete and embryo assessment is considered an important focus in assisted reproductive technologies (ART). Currently, the selection of embryos for transfer is based on morphological indices. Though successful, the field of ART would benefit from a noninvasive quantitative method of viability determination. Omics technologies, including transcriptomics, proteomics and metabolomics, have already begun providing evidence that viable gametes and embryos possess unique molecular profiles with potential biomarkers that can be utilized for developmental and/or viability selection. Unlike the human genome that is relatively fixed and steady throughout the human body, the human proteome, estimated at over a million proteins, is more complex, diverse and dynamic. It is the proteins themselves that contribute to the physiological homeostasis in any cell or tissue. Of particular interest in ART is the secretome, those proteins that are produced within the embryo and secreted into the surrounding environment. Defining the human embryonic secretome has the potential to expand our knowledge of embryonic cellular processes, including the complex dialogue between the developing embryo and its maternal environment, and may also assist in identifying those embryos with the highest implantation potential. Advances in proteomic technologies have allowed the non-invasive profiling of the human embryonic secretome with ongoing research focused on correlation with outcome. From a clinical perspective, embryo selection based on morphological assessment and non-invasive analysis of the human embryonic secretome may improve IVF success and lead to routine single embryo transfers.


REFERENCES

  1. Dominguez DC, Lopes R, Torres ML. Proteomics: clinical applications. Clin Lab Sci 2007;20:245-248.

  2. Hathout Y. Approaches to the study of the cell secretome. Expert Rev Proteomics 2007;4:239-248.

  3. Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics 2006;6:6326-6353.

  4. Kulasingam V, Diamandis EP. Proteomics analysis of conditioned media from three breast cell lines: a mine for biomarkers and therapeutic targets. Mol Cell Proteomics 2007;6:1997-2011.

  5. Ebner T, Moser M, Sommergruber M, Tews G. Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review. Hum Reprod Update 2003;9:251-262.

  6. Sakkas D, Gardner DK. Noninvasive methods to assess embryo quality. Curr Opin Obstet Gynecol 2005;17:283-288.

  7. Stern JE, Cedars MI, Jain T, Klein NA, et al. Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States. Fertil Steril 2007;88:275-282.

  8. Pinborg A. IVF/ICSI twin pregnancies: risks and prevention. Hum Reprod Update 2005;11:575-593.

  9. Williamson AJ, Smith DL, Blinco D, Unwin RD, et al. Quantitative proteomics analysis demonstrates post-transcriptional regulation of embryonic stem cell differentiation to hematopoiesis. Mol Cell Proteomics 2008;7:459-472.

  10. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-1730.

  11. Latham KE, Garrels JI, Chang C, Solter D. Analysis of embryonic mouse development: construction of a highresolution, two-dimensional gel protein database. Appl Theor Electrophor 1992;2:163-170.

  12. Shi CZ, Collins HW, Garside WT, Buettger CW, et al. Protein databases for compacted eight-cell and blastocyst-stage mouse embryos. Mol Reprod Dev 1994;37:34-47.

  13. Navarrete Santos A, Tonack S, Kirstein M, Kietz S, Fischer B. Two insulin-responsive glucose transporter isoforms and the insulin receptor are developmentally expressed in rabbit preimplantation embryos. Reproduction 2004;128:503-516.

  14. Wang Y, Puscheck EE, Lewis JJ, Trostinskaia AB, et al. Increases in phosphorylation of SAPK/JNK and p38MAPK correlate negatively with mouse embryo development after culture in different media. Fertil Steril 2005;1:1144-1154.

  15. Gutstein HB, Morris JS, Annangudi SP, Sweedler JV. Microproteomics: analysis of protein diversity in small samples. Mass Spectrom Rev 2008;27:316-330.

  16. Jansen C, Hebeda KM, Linkels M, Grefte JM, et al. Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology. Cell Oncol 2008;30:27-38.

  17. Seibert V, Wiesner A, Buschmann T, Meuer J. Surfaceenhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research. Pathol Res Pract 2004;200:83-94.

  18. Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 2007;6:25.

  19. Liebler DC. Introduction to Proteomics: Tools for the New Biology. New Jersey: Humana Press; 2002.

  20. Sutovsky P, Manandhar G, Laurincik J, Letko J, et al. Expression and proteasomal degradation of the major vault protein (MVP) in mammalian oocytes and zygotes. Reproduction 2005;129:269-282.

  21. Katz-Jaffe MG, Linck DW, Schoolcraft WB, Gardner DK. A proteomic analysis of mammalian preimplantation embryonic development. Reproduction 2005;130:899-905.

  22. Katz-Jaffe MG, Gardner DK, Schoolcraft WB. Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability. Fertil Steril 2006a;85:101-107.

  23. Hu J, Coombes KR, Morris JS, Baggerly KA. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct Genomic Proteomic 2005;3:322-331.

  24. O’Neill C. The role of paf in embryo physiology. Hum Reprod Update 2005;11:215-228.

  25. Gonzalez RR, Caballero-Campo P, Jasper M, Mercader A, et al. Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. J Clin Endocrinol Metab 2000;85:4883-4888.

  26. Cervero A, Horcajadas JA, Dominguez F, Pellicer A, Simon C. Leptin system in embryo development and implantation: a protein in search of a function. Reprod Biomed Online 2005;10:217-223.

  27. Díaz-Cueto L, Stein P, Jacobs A, Schultz RM, Gerton GL. Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor). Dev Biol 2000;217:406-418.

  28. Sakkas D, Lu C, Zulfikaroglu E, Neuber E, Taylor HS. A soluble molecule secreted by human blastocysts modulates regulation of HOXA10 expression in an epithelial endometrial cell line. Fertil Steril 2003;80:1169-1174.

  29. Noci I, Fuzzi B, Rizzo R, Melchiorri L, et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005;20:138-146.

  30. Sher G, Keskintepe L, Fisch JD, Acacio BA, et al. Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil Steril 2005;83:1410-1413.

  31. Sargent I, Swales A, Ledee N, Kozma N, et al. sHLA-G production by human IVF embryos: can it be measured reliably? J Reprod Immunol 2007;75:128-132.

  32. Katz-Jaffe MG, Schoolcraft WB, Gardner DK. Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertil Steril 2006;86:678-685.

  33. Telford NA, Watson AJ, Schultz GA. Transition from maternal to embryonic control in early mammalian development: a comparison of several species. Mol Reprod Dev 1990;26:90-100.

  34. Sandoval JA, Hoelz DJ, Woodruff HA, Powell RL, et al. Novel peptides secreted from human neuroblastoma: useful clinical tools? J Pediatr Surg 2006;41:245-251.

  35. Delbosc S, Haloui M, Louedec L, Dupuis M, et al. Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol Med 2008;14:383-394.

  36. Wang HM, Zhang X, Qian D, Lin HY, et al. Effect of ubiquitinproteasome pathway on mouse blastocyst implantation and expression of matrix metalloproteinases-2 and -9. Biol Reprod 2004;70:481-487.

  37. Katz-Jaffe MG, Stevens J, Kearns WG, Gardner DK, Schoolcraft WB. Relationship between embryonic secretome and chromosomal abnormalities in human IVF. Fertil Steril 2006;86:S57.

  38. Fragouli E, Lenzi M, Ross R, Katz-Jaffe MG, et al. Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod 2008;23:2596-2608.

  39. Katz-Jaffe MG, Fagouli E, Fillipovits J, Wells D, Schoolcraft WB. Relationship between the human blastocyst secretome and chromosomal constitution. Fertl Steril 2008;90:S80.

  40. Dominguez F, Gadea B, Esteban FJ, Horcajadas JA, et al. Comparative protein-profile analysis of implanted versus non-implanted human blastocysts. Hum Reprod 2008;23:1993-2000.

  41. Robertson SA. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev 2007;18:287-298.

  42. Spisak S, Tulassay Z, Molnar B, Guttman A. Protein microchips in biomedicine and biomarker discovery. Electrophoresis 2007;28:4261-4273.

  43. Brison DR, Hollywood K, Arneson R, Goodacre R. Predicting human embryo viability: the road to non-invasive analysis of the secretome using metabolic footprinting. Reprod Biomed Online 2007;15:296-302.

  44. Seli E, Sakkas D, Scott R, Kwok SC, et al. Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in vitro fertilization. Fertil Steril 2007;88:1350-1357.

  45. Scott R, Seli E, Miller K, Sakkas D, et al. Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study. Fertil Steril 2008;90:77-83.




2020     |     www.medigraphic.com